Vestigial Like 2 (VGLL2) (C-Term) Peptide
-
- Target See all VGLL2 products
- VGLL2 (Vestigial Like 2 (VGLL2))
- Protein Region
- C-Term
- Origin
- Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- APASAPAPGS PPCELAAKGE PAGSAWAAPG GPFVSPTGDV AQSLGLSVDS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Vgll2 Antibody(ARP37509_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- VGLL2 (Vestigial Like 2 (VGLL2))
- Synonyms
- VGL2 Peptide, VITO1 Peptide, vgll2a Peptide, MGC114146 Peptide, zgc:114146 Peptide, C130057C21Rik Peptide, VITO-1 Peptide, Vito1 Peptide, vgl-2 Peptide, zgc:110098 Peptide, vestigial like family member 2 Peptide, vestigial-like family member 2 Peptide, vestigial-like family member 2a Peptide, vestigial like family member 2 L homeolog Peptide, vestigial-like family member 2b Peptide, VGLL2 Peptide, Vgll2 Peptide, vgll2a Peptide, vgll2.L Peptide, vgll2b Peptide
- Background
-
Vgll2 may act as a specific coactivator for the mammalian TEFs. May play a role in the development of skeletal muscles.
Alias Symbols: C130057C21Rik, VITO-1, Vito1
Protein Size: 322 - Molecular Weight
- 34 kDa
- Gene ID
- 215031
- NCBI Accession
- NM_153786, NP_722481
- UniProt
- Q8BGW8
-